Carole Huntsman, Chief Commercial Officer at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 3,236 shares at $547.27 ($1.8M) on 2025-11-21, disclosed to the SEC on 2025-11-21.
Scheduled sale ($1.8M) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $547.27 | 144 | $79K | 4.4% |
| 2 | $547.27 | 144 | $79K | 4.4% |
| 3 | $548.71 | 120 | $66K | 3.7% |
| 4 | $548.71 | 120 | $66K | 3.7% |
| 5 | $549.34 | 40 | $22K | 1.2% |
| 6 | $550.97 | 894 |
| $493K |
| 27.6% |
| 7 | $550.97 | 894 | $493K | 27.6% |
| 8 | $552.38 | 200 | $110K | 6.2% |
| 9 | $553.23 | 40 | $22K | 1.2% |
| 10 | $556.04 | 120 | $67K | 3.7% |
| 11 | $556.04 | 120 | $67K | 3.7% |
| 12 | $559.60 | 200 | $112K | 6.3% |
| 13 | $560.62 | 80 | $45K | 2.5% |
| 14 | $563.21 | 40 | $23K | 1.3% |
| 15 | $564.57 | 80 | $45K | 2.5% |
| Total | $552.20 avg | 3,236 | $1.8M | 100% |
| Filing → |
| MDGL | SELL | 2025-03-05 | $727K | — | Filing → |
| MDGL | SELL | 2025-01-27 | $233K | — | Filing → |
| MDGL | SELL | 2024-11-22 | $436K | — | Filing → |